Advertisement
Screener

TransMedics Group, Inc. (TMDX) Increase Decrease In Operating Lease Liability

TransMedics Group, Inc. Increase Decrease In Operating Lease Liability

TransMedics Group, Inc. (TMDX) reported Increase Decrease In Operating Lease Liability of -$1.59 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-04

  • TransMedics Group, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$783.00K.
  • TransMedics Group, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$805.00K.
  • TransMedics Group, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$777.00K.
  • TransMedics Group, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$740.00K.
  • TransMedics Group, Inc. increase decrease in operating lease liability for fiscal 2025 was -$2.90M.
  • TransMedics Group, Inc. increase decrease in operating lease liability for fiscal 2024 was -$2.27M.
  • TransMedics Group, Inc. increase decrease in operating lease liability for fiscal 2023 was -$1.57M, a 717.25% decline from fiscal 2022.
  • TransMedics Group, Inc. increase decrease in operating lease liability for fiscal 2022 was $255.00K, a 8.05% increase from fiscal 2021.
Period endIncrease Decrease In Operating Lease Liability 3 monthIncrease Decrease In Operating Lease Liability 6 monthIncrease Decrease In Operating Lease Liability 9 monthIncrease Decrease In Operating Lease Liability 12 month
2026-06-30-$783.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
-$1.59M
10-Q · filed 2026-08-04
-$2.37M
derived: sum of 3 quarters · filed 2026-08-04
-$3.10M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31-$805.00K
10-Q · filed 2026-05-05
-$1.58M
derived: sum of 2 quarters · filed 2026-05-05
-$2.32M
derived: sum of 3 quarters · filed 2026-05-05
-$3.04M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31-$777.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$1.52M
derived: sum of 2 quarters · filed 2026-02-24
-$2.23M
derived: sum of 3 quarters · filed 2026-08-04
-$2.90M
10-K · filed 2026-02-24
2025-09-30-$740.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
-$1.45M
derived: sum of 2 quarters · filed 2026-08-04
-$2.12M
10-Q · filed 2025-10-29
-$2.76M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30-$714.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
-$1.38M
10-Q · filed 2026-08-04
-$2.02M
derived: sum of 3 quarters · filed 2026-08-04
-$2.64M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31-$664.00K
10-Q · filed 2026-05-05
-$1.30M
derived: sum of 2 quarters · filed 2026-05-05
-$1.93M
derived: sum of 3 quarters · filed 2026-05-05
-$2.43M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31-$639.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$1.26M
derived: sum of 2 quarters · filed 2026-02-24
-$1.77M
derived: sum of 3 quarters · filed 2026-02-24
-$2.27M
10-K · filed 2026-02-24
2024-09-30-$626.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
-$1.13M
derived: sum of 2 quarters · filed 2025-10-29
-$1.63M
10-Q · filed 2025-10-29
-$2.10M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30-$504.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30
-$1.00M
10-Q · filed 2025-07-30
-$1.47M
derived: sum of 3 quarters · filed 2026-02-24
-$1.83M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31-$496.00K
10-Q · filed 2025-05-08
-$969.00K
derived: sum of 2 quarters · filed 2026-02-24
-$1.33M
derived: sum of 3 quarters · filed 2026-02-24
-$1.72M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31-$473.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$832.00K
derived: sum of 2 quarters · filed 2026-02-24
-$1.22M
derived: sum of 3 quarters · filed 2026-02-24
-$1.57M
10-K · filed 2026-02-24
2023-09-30-$359.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
-$749.00K
derived: sum of 2 quarters · filed 2024-10-29
-$1.10M
10-Q · filed 2024-10-29
-$1.44M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$390.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01
-$742.00K
10-Q · filed 2024-08-01
-$1.08M
derived: sum of 3 quarters · filed 2025-02-27
-$1.41M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$352.00K
10-Q · filed 2024-05-02
-$687.00K
derived: sum of 2 quarters · filed 2025-02-27
-$1.01M
derived: sum of 3 quarters · filed 2025-02-27
-$1.34M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31-$335.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$663.00K
derived: sum of 2 quarters · filed 2025-02-27
-$986.00K
derived: sum of 3 quarters · filed 2025-02-27
$255.00K
10-K · filed 2025-02-27
2022-09-30-$328.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
-$651.00K
derived: sum of 2 quarters · filed 2023-11-08
$590.00K
10-Q · filed 2023-11-08
2022-06-30-$323.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
$918.00K
10-Q · filed 2023-08-04
2022-03-31$1.24M
10-Q · filed 2023-05-04
2021-12-31$236.00K
10-K · filed 2024-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Axogen, Inc. (AXGN)United States$2.329B-73.83
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
LivaNova PLC (LIVN)$4.158B24.01
Integer Holdings Corp (ITGR)United States$4.289B25.17
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53